GO:1902824 positive regulation of late endosome to lysosome transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902824 describes any process that activates or increases the frequency, rate or extent of late endosome to lysosome transport, a critical step in endolysosomal degradation and cellular homeostasis.
• Key molecular players include Rab7, Arl8b, TBC1D15, the ESCRT machinery (CHMP2B), and the SKIP-HOPS complex, which coordinate the conversion of late endosomes to lysosomes [1, 2, 5].
• Dysregulation of this process is linked to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) through CHMP2B mutations, and to atherosclerosis via NPC1-mediated cholesterol trafficking [2, 3].
• Live-cell imaging and genetic perturbation (e.g., Rab7 knockdown) are powerful methods to study late endosome transport regulation [7, 8].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of gene function in this pathway.
• Understanding GO:1902824 provides insights into cargo degradation, nutrient sensing, and potential therapeutic targets for lysosomal storage disorders and cancer.
Description
The endolysosomal system is essential for the degradation and recycling of cellular material, and the transport of late endosomes to lysosomes represents a key regulatory node in this pathway. GO:1902824, positive regulation of late endosome to lysosome transport, encompasses any process that activates or increases the frequency, rate or extent of this transport step. This term is critical for researchers studying membrane trafficking, organelle maturation, and diseases linked to endosomal dysfunction [1, 5]. The transition from late endosome to lysosome requires a coordinated series of molecular events, including Rab conversion, tethering, and fusion, which are tightly regulated by protein complexes such as ESCRT and SKIP-HOPS [1, 5]. Defects in these regulators can lead to accumulation of undegraded cargo, contributing to neurodegeneration and metabolic disorders [2, 3]. Thus, understanding the positive regulation of late endosome to lysosome transport is fundamental for both basic cell biology and translational research.
positive regulation of late endosome to lysosome transport At A Glance
| GO ID | GO:1902824 |
|---|---|
| GO term | positive regulation of late endosome to lysosome transport |
| Ontology | biological_process |
| Synonym | activation of late endosome to lysosome transport; up regulation of late endosome to lysosome transport; up-regulation of late endosome to lysosome transport; upregulation of late endosome to lysosome transport |
| Major function | Enhances the transport of cargo from late endosomes to lysosomes for degradation |
| Related cellular component | Late endosome, lysosome, endosomal sorting complex required for transport (ESCRT) |
| Related molecular function | Rab GTPase activity, tethering and fusion regulation |
| Key regulators | Rab7, Arl8b, TBC1D15, CHMP2B, SKIP-HOPS complex |
| Disease relevance | Neurodegeneration, atherosclerosis, lysosomal storage disorders |
What Is GO:1902824?
GO:1902824 is defined as any process that activates or increases the frequency, rate or extent of late endosome to lysosome transport. In other words, it covers the molecular mechanisms that promote the movement and fusion of late endosomes with lysosomes, ensuring efficient degradation of cargo. This regulation can occur through protein-protein interactions, post-translational modifications, or changes in lipid composition that enhance the transport process [1, 5].
Why Is positive regulation of late endosome to lysosome transport Important in Cell Biology?
Positive regulation of late endosome to lysosome transport is vital for cellular homeostasis because it controls the degradation of signaling receptors, lipids, and damaged organelles. Impaired regulation leads to the accumulation of toxic materials, which is a hallmark of neurodegenerative diseases such as ALS and FTD, and contributes to metabolic disorders like atherosclerosis [2, 3]. Moreover, this process is exploited by pathogens and is implicated in cancer progression, making it a target for therapeutic intervention [1, 5].
• Maintains cellular homeostasis by ensuring efficient degradation of endocytosed cargo.
• Regulates nutrient sensing and mTORC1 signaling through lysosomal positioning.
• Dysfunction is linked to neurodegenerative diseases (e.g., ALS, FTD) via CHMP2B mutations.
• Implicated in cholesterol trafficking and atherosclerosis through NPC1.
• Plays a role in antigen presentation and immune responses.
• Affects neuronal survival by controlling degradation of dendritic cargos.
• Provides targets for cancer therapy, as altered endolysosomal trafficking supports tumor growth.
• Key for understanding lysosomal storage disorders and potential treatments.
• Regulated by Rab7-to-Arl8b conversion, a critical switch in endosome maturation.
• Studied using advanced live-cell imaging to visualize endosome maturation.
What Happens During positive regulation of late endosome to lysosome transport?
Rab7 Recruitment and Activation
In simple terms: Rab7 is a molecular switch that helps late endosomes move toward lysosomes.
The small GTPase Rab7 is a master regulator of late endosome transport. Its recruitment to late endosomes is promoted by the SKIP-HOPS complex, which recruits TBC1D15 to facilitate a Rab7-to-Arl8b identity switch, thereby enhancing transport to lysosomes. Rab7 activation is required for the movement of late endosomes along microtubules and their subsequent fusion with lysosomes [1, 7].
ESCRT-Mediated Sorting and Membrane Remodeling
In simple terms: ESCRT proteins help sort cargo into late endosomes and shape the membrane for transport.
The ESCRT machinery, including CHMP2B, is essential for the formation of intraluminal vesicles and the sorting of cargo into late endosomes. Mutations in CHMP2B, such as truncation, disrupt late endosome function but can also reduce TDP-43 aggregation through HSP70 upregulation, highlighting the complex interplay between ESCRT function and neurodegeneration. ESCRT components also coordinate with Rab conversion to ensure proper late endosome maturation.
Tethering and Fusion with Lysosomes
In simple terms: Tethering proteins bring late endosomes close to lysosomes so they can fuse and deliver cargo.
Once late endosomes are properly matured, tethering factors and SNARE proteins mediate their fusion with lysosomes. The SKIP-HOPS complex and TBC1D15 regulate this step by promoting the Rab7-to-Arl8b switch, which is necessary for efficient transport. Live-cell imaging assays have revealed that endosome maturation is regulated by a series of signaling events that can be visualized in real time.
Cargo Degradation and Recycling
In simple terms: After fusion, the cargo is broken down and the building blocks are recycled.
Following fusion, lysosomal hydrolases degrade the cargo, and the resulting metabolites are transported back to the cytoplasm. This process is crucial for neuronal function, as degradation of dendritic cargos requires Rab7-dependent transport to somatic lysosomes. Defects in this step can lead to the accumulation of undegraded material, contributing to disease [2, 3].
Key Genes Involved in GO:1902824 positive regulation of late endosome to lysosome transport
The following genes and proteins are key players in the positive regulation of late endosome to lysosome transport, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAB7 | Small GTPase that regulates late endosome transport and fusion with lysosomes | Central regulator; knockdown inhibits transport |
| ARL8B | GTPase involved in lysosome positioning and fusion | Works downstream of Rab7 in endosome maturation |
| TBC1D15 | Rab7 GAP that promotes Rab7-to-Arl8b switch | Recruited by SKIP-HOPS to control late endosome transport |
| CHMP2B | ESCRT-III component required for late endosome function | Mutations linked to ALS/FTD; truncation disrupts transport |
| VPS4 | AAA-ATPase that disassembles ESCRT complexes | Regulates ESCRT cycling and late endosome sorting |
| SKIP | Component of SKIP-HOPS complex that recruits TBC1D15 | Essential for Rab7-to-Arl8b conversion |
| HOPS | Tethering complex that mediates late endosome-lysosome fusion | Works with SKIP to regulate transport |
| NPC1 | Cholesterol transporter in late endosomes/lysosomes | Mutations cause Niemann-Pick type C; affects cholesterol trafficking |
| ERBB3 | Receptor tyrosine kinase that undergoes endosomal sorting | Regulated by PKC; turnover linked to late endosome transport |
| TYRP1 | Melanosomal protein trafficked through late endosomes | Model for studying transport from TGN to melanosomes |
| HSP70 | Chaperone that can be upregulated upon CHMP2B mutation | Modifies TDP-43 aggregation in neurodegeneration |
| TDP-43 | RNA-binding protein that aggregates in ALS/FTD | Aggregation reduced by CHMP2B truncation via HSP70 |
| LAMP1 | Lysosomal marker used to assess fusion | Common marker for lysosome fusion assays |
| RILP | Rab7 effector that links late endosomes to dynein | Facilitates transport toward lysosomes |
| ORP1L | Cholesterol sensor that regulates Rab7 positioning | Involved in late endosome motility |
| SNARE proteins | Mediate membrane fusion between late endosomes and lysosomes | Essential for final fusion step |
| mTORC1 | Kinase complex that senses nutrients and regulates lysosome positioning | Regulates late endosome transport indirectly |
How Is positive regulation of late endosome to lysosome transport Regulated?
The positive regulation of late endosome to lysosome transport is controlled by multiple signaling pathways. The SKIP-HOPS complex recruits TBC1D15 to promote a Rab7-to-Arl8b identity switch, which is a key regulatory event. Additionally, protein kinase C (PKC) regulates ErbB3 turnover, which involves late endosome transport. Cholesterol levels also modulate this process through NPC1, affecting intracellular cholesterol trafficking. Furthermore, live-cell imaging has revealed that endosome maturation is regulated by a series of signaling events that can be visualized in real time.
positive regulation of late endosome to lysosome transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CHMP2B | ALS/FTD; disrupted late endosome function | Knockout or point mutation in iPSC-derived neurons |
| NPC1 | Niemann-Pick type C; atherosclerosis | Knockout in hepatocytes or macrophages |
| RAB7 | Charcot-Marie-Tooth disease type 2B; neurodegeneration | Knockdown or knockout in neuronal cells |
| ERBB3 | Cancer; receptor turnover | Overexpression or point mutation in cancer cell lines |
| TBC1D15 | Neurodegeneration; endosome maturation | Knockout in HeLa cells or primary neurons |
Neurodegenerative Diseases
Mutations in CHMP2B, a component of the ESCRT-III complex, disrupt late endosome function and are associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Interestingly, a truncation mutation in CHMP2B reduces TDP-43 aggregation through HSP70 upregulation, suggesting a complex interplay between endosomal dysfunction and protein aggregation in neurodegeneration. Additionally, Rab7-dependent transport is required for the degradation of dendritic cargos, and its impairment contributes to neuronal dysfunction.
Atherosclerosis and Cholesterol Trafficking
NPC1 is a key protein in late endosomal cholesterol trafficking, and its dysfunction leads to Niemann-Pick type C disease and contributes to atherosclerosis. NPC1 mutations cause cholesterol accumulation in late endosomes, highlighting the importance of proper late endosome to lysosome transport in lipid homeostasis.
Cancer and Receptor Turnover
Altered endolysosomal trafficking can affect the turnover of receptor tyrosine kinases such as ErbB3, which is regulated by protein kinase C. This regulation impacts downstream signaling and may contribute to cancer progression. Furthermore, the ESCRT machinery and Rab conversion are often hijacked in cancer cells to promote growth factor receptor degradation or recycling.
From positive regulation of late endosome to lysosome transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CHMP2B affect late endosome transport? | CHMP2B knockout cell line (e.g., HeLa, SH-SY5Y) |
| How does Rab7 mutation affect cargo degradation? | Rab7 point mutation (e.g., Q67L) knock-in |
| Can overexpression of TBC1D15 enhance transport? | TBC1D15 overexpression in neuronal cells |
| What is the role of NPC1 in cholesterol trafficking? | NPC1 knockout in macrophages |
| How does ErbB3 sorting regulate signaling? | ErbB3 tagged knock-in for live imaging |
| Does SKIP-HOPS complex assembly require specific domains? | Domain-specific knock-in mutations |
How to Study the positive regulation of late endosome to lysosome transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Real-time transport dynamics | Visualizing endosome maturation |
| CRISPR knockout | Gene function loss | Studying Rab7 or CHMP2B [2, 7] |
| RNAi knockdown | Transient gene silencing | Assessing TBC1D15 role |
| Proteomics | Protein interactions and complexes | Identifying SKIP-HOPS components |
| Colocalization microscopy | Overlap of endosome and lysosome markers | Quantifying fusion efficiency |
| Western blot | Protein levels and degradation | Measuring ErbB3 turnover |
| Flow cytometry | Cargo degradation in populations | High-throughput screening |
Live-Cell Imaging
Live-cell imaging allows real-time visualization of late endosome to lysosome transport. A novel assay developed by Podinovskaia et al. (2021) enables monitoring of endosome maturation and regulation. This method is ideal for studying dynamic changes in response to genetic perturbations.
Genetic Knockdown and Knockout
RNAi or CRISPR-Cas9 knockout of key genes such as RAB7, CHMP2B, or TBC1D15 can reveal their roles in transport. For example, Rab7 knockdown inhibits dendritic cargo degradation, demonstrating its necessity.
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify protein complexes involved in transport regulation, such as the SKIP-HOPS complex. Proximity labeling or co-immunoprecipitation can validate interactions.
Fluorescence Microscopy and Colocalization
Colocalization of late endosome markers (e.g., Rab7, LAMP1) with lysosomal markers can quantify transport efficiency. This approach is used to assess the effects of mutations in CHMP2B or NPC1 [2, 3].
How CRISPR Can Be Used to Study GO:1902824 positive regulation of late endosome to lysosome transport
Knockout
CRISPR knockout of genes such as RAB7, CHMP2B, or TBC1D15 can abolish or reduce late endosome to lysosome transport, providing causal evidence for their roles. For instance, CHMP2B knockout recapitulates aspects of ALS/FTD pathology.
Point Mutation
Introducing disease-associated point mutations (e.g., CHMP2B truncation) via CRISPR can model human disease and reveal mechanistic insights. Point mutations in RAB7 can also be used to study GTPase cycling [2, 7].
Knock-in
Knock-in of tagged proteins (e.g., GFP-Rab7) allows live-cell imaging of transport in physiological conditions. This approach is valuable for tracking endogenous protein dynamics.
Overexpression
Overexpression of positive regulators such as TBC1D15 or Arl8b can enhance transport and rescue defects. This strategy can identify rate-limiting steps and potential therapeutic targets.
How EDITGENE Supports positive regulation of late endosome to lysosome transport Research
Researchers studying positive regulation of late endosome to lysosome transport-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional validation.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of late endosome to lysosome transport research.
Frequently Asked Questions About positive regulation of late endosome to lysosome transport
What is GO:1902824?
GO:1902824 is a Gene Ontology term for any process that activates or increases the frequency, rate or extent of late endosome to lysosome transport.
What genes are involved in positive regulation of late endosome to lysosome transport?
Key genes include RAB7, ARL8B, TBC1D15, CHMP2B, and components of the SKIP-HOPS complex [1, 2, 5].
How is late endosome to lysosome transport regulated?
It is regulated by Rab GTPase conversion, ESCRT-mediated sorting, and tethering complexes such as SKIP-HOPS [1, 5].
What diseases are associated with defects in this process?
Neurodegenerative diseases like ALS and FTD, atherosclerosis, and lysosomal storage disorders [2, 3].
What methods are used to study late endosome to lysosome transport?
Live-cell imaging, CRISPR knockout, RNAi, proteomics, and colocalization microscopy [5, 7, 8].
How does CHMP2B mutation affect late endosome function?
Truncation mutation of CHMP2B disrupts late endosome function but reduces TDP-43 aggregation through HSP70 upregulation.
What is the role of Rab7 in this process?
Rab7 is a small GTPase that regulates late endosome transport and fusion with lysosomes; its knockdown inhibits cargo degradation.
Can CRISPR be used to study this pathway?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this pathway.
What is the SKIP-HOPS complex?
SKIP-HOPS recruits TBC1D15 for a Rab7-to-Arl8b identity switch to control late endosome transport.
How does NPC1 relate to late endosome transport?
NPC1 is a cholesterol transporter in late endosomes/lysosomes; mutations cause cholesterol accumulation and are linked to atherosclerosis.
Conclusion
The positive regulation of late endosome to lysosome transport (GO:1902824) is a fundamental cellular process that ensures proper degradation of cargo and maintains homeostasis. Dysregulation of this pathway is implicated in a range of diseases, from neurodegeneration to atherosclerosis. Advances in CRISPR-based models and live-cell imaging continue to unravel the molecular mechanisms, offering potential therapeutic targets. EDITGENE's comprehensive services support researchers in dissecting this pathway with precision.
References
- 1. Solinger JA et al.. 2025. ESCRTing the RABs through conversion.. Biochem Soc Trans 53(2):431-445 PMID: 40605338
- 2. Iguchi Y et al.. 2025. Truncation mutation of CHMP2B disrupts late endosome function but reduces TDP-43 aggregation through HSP70 upregulation.. Neurochem Int 187:105982 PMID: 40316175
- 3. Yu XH et al.. 2014. NPC1, intracellular cholesterol trafficking and atherosclerosis.. Clin Chim Acta 429:69-75 PMID: 24296264
- 4. Dietrich M et al.. 2019. Protein kinase C regulates ErbB3 turnover.. Exp Cell Res 382(2):111473 PMID: 31233741
- 5. Jongsma ML et al.. 2020. SKIP-HOPS recruits TBC1D15 for a Rab7-to-Arl8b identity switch to control late endosome transport.. EMBO J 39(6):e102301 PMID: 32080880
- 6. Jimbow K et al.. 1997. Biological role of tyrosinase related protein and its biosynthesis and transport from TGN to stage I melanosome, late endosome, through gene transfection study.. Pigment Cell Res 10(4):206-13 PMID: 9263327
- 7. Yap CC et al.. 2018. Degradation of dendritic cargos requires Rab7-dependent transport to somatic lysosomes.. J Cell Biol 217(9):3141-3159 PMID: 29907658
- 8. Podinovskaia M et al.. 2021. A novel live-cell imaging assay reveals regulation of endosome maturation.. Elife 10 PMID: 34846303
